#angioedema — Thursday, October 08, 2026 (1 items)
| 19 | ℹ |
Oral deucrictibant for on-demand treatment of hereditary angioedema attacks: a phase 3, multicentre, randomised, double-blind, placebo-controlled crossover trial.
(linkinghub.elsevier.com)
|
The Lancet 2026-10-08 | #angioedema #clinical trial #hereditary #pharmacotherapy #bradykinin |